Skip to main content
SpringerLink
Log in

Diagnostic Criteria for Giant Cell Arteritis

  • Chapter
  • First Online:
Ischemic Optic Neuropathies

  • 1256 Accesses

Abstract

Giant cell arteritis (GCA) is the most important ­medical emergency in ophthalmology, as was rightly stressed by Kearns [1] when he stated that GCA “ranks as the prime medical emergency in ophthalmology, there being no other disease in which the prevention of blindness depends so much on prompt recognition and early treatment.” A study [2] further emphasized that fact, when it found that a high proportion of patients with permanent visual loss have a delayed diagnosis and treatment; in that study 35% had systemic symptoms for an average of 10.8 months before visual loss and 65% had premonitory visual symptoms for an average of 8.5 days.

For a complete bibliography and detailed review of previously published studies in the literature on the subject, please refer to bibliography in previous publications listed here.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kearns TP. Collagen and rheumatic diseases: ophthalmic aspects. In: Mausolf FA, editor. The eye and systemic disease. St. Louis: Mosby; 1975. p. 105–18.

    Google Scholar 

  2. Font C, Cid MC, Coll-Vinent B, Lopez-Soto A, Grau JM. Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. Br J Rheumatol. 1997;36(2):251–4.

    Article  PubMed  CAS  Google Scholar 

  3. Hazelman BL, Bengtsson BA. Giant cell arteritis and polymyalgia rheumatica. Baillières Clin Rheumatol. 1991;5:371–507.

    Article  Google Scholar 

  4. Hayreh SS. Anterior ischaemic optic neuropathy I. Terminology and pathogenesis. Br J Ophthalmol. 1974;58(12):955–63.

    Article  PubMed  CAS  Google Scholar 

  5. Hayreh SS. Anterior ischaemic optic neuropathy II. Fundus on ophthalmoscopy and fluorescein angiography. Br J Ophthalmol. 1974;58(12):964–80.

    Article  PubMed  CAS  Google Scholar 

  6. Hayreh SS. Pathogenesis of cupping of the optic disc. Br J Ophthalmol. 1974;58(10):863–76.

    Article  PubMed  CAS  Google Scholar 

  7. Hayreh SS. Anterior ischemic optic neuropathy. New York: Springer-Verlag; 1975.

    Google Scholar 

  8. Hayreh SS. Anterior ischemic optic neuropathy. Arch Neurol. 1981;38(11):675–8.

    PubMed  CAS  Google Scholar 

  9. Hayreh SS. Posterior ischemic optic neuropathy. Ophthalmologica. 1981;182(1):29–41.

    Article  PubMed  CAS  Google Scholar 

  10. Hayreh SS. Anterior ischaemic optic neuropathy differentiation of arteritic from non-arteritic type and its management. Eye. 1990;4(1):25–41.

    Article  PubMed  Google Scholar 

  11. Hayreh SS. Ophthalmic features of giant cell arteritis. Baillières Clin Rheumatol. 1991;5(3):431–59.

    Article  PubMed  CAS  Google Scholar 

  12. Hayreh SS. Acute ischemic disorders of the optic nerve – pathogenesis, clinical manifestations, and management. Ophthalmol Clin North Am. 1996;9(4):407–42.

    Google Scholar 

  13. Hayreh SS, Podhajsky PA, Raman R, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol. 1997;123(3):285–96.

    PubMed  CAS  Google Scholar 

  14. Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol. 1998;125(4):509–20.

    Article  PubMed  CAS  Google Scholar 

  15. Hayreh SS, Podhajsky PA, Zimmerman B. Occult giant cell arteritis: ocular manifestations. Am J Ophthalmol. 1998;125((4):521–6. 893.

    Article  PubMed  CAS  Google Scholar 

  16. Hayreh SS. Masticatory muscle pain: an important indicator of giant cell arteritis. Spec Care Dentist. 1998;18(2):60–5.

    Article  PubMed  CAS  Google Scholar 

  17. Hayreh SS. Ocular manifestations of giant cell arteritis. Am J Ophthalmol. 1998;126:743–4.

    Google Scholar 

  18. Hayreh SS. Steroid therapy for visual loss in patients with giant-cell arteritis. Lancet. 2000;355(9215):1572–3.

    Article  PubMed  CAS  Google Scholar 

  19. Hayreh SS, Jonas JB. Optic Disc morphology after Arteritic Anterior Ischemic Optic Neuropathy. Ophthalmology. 2001;108(9):1586–94.

    Article  PubMed  CAS  Google Scholar 

  20. Hayreh SS, Zimmerman B, Kardon RH. Visual improvement with corticosteroid therapy in giant cell arteritis report of a large study and review of literature. Acta Ophthalmol Scand. 2002;80(4):355–67.

    Article  PubMed  Google Scholar 

  21. Hayreh SS, Zimmerman B. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Ophthalmology. 2003;110(6):1204–15.

    Article  PubMed  Google Scholar 

  22. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347(4):261–71.

    Article  PubMed  Google Scholar 

  23. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372(9634):234–45.

    Article  PubMed  Google Scholar 

  24. Cohen MD, Ginsburg WW. Polymyalgia rheumatica. Rheum Dis Clin North Am. 1990;16(2):325–39.

    PubMed  CAS  Google Scholar 

  25. Healey LA. Relation of giant cell arteritis to polymyalgia rheumatica. Baillières Clin Rheumatol. 1991;5(3):371–8.

    Article  PubMed  CAS  Google Scholar 

  26. Wilke WS, Hoffman GS. Treatment of corticosteroid-resistant giant cell arteritis. Rheum Dis Clin North Am. 1995;21(1):59–71.

    PubMed  CAS  Google Scholar 

  27. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American college of rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122–8.

    Article  PubMed  CAS  Google Scholar 

  28. Zweegman S, Makkink B, Stehouwer CD. Giant-cell arteritis with normal erythrocyte sedimentation rate: case report and review of the literature. Neth J Med. 1993;42(3–4):128–31.

    PubMed  CAS  Google Scholar 

  29. Salvarani C, Hunder GG. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study. Arthritis Rheum. 2001;45(2):140–5.

    Article  PubMed  CAS  Google Scholar 

  30. Sparrow D, Rowe JW, Silbert JE. Cross-sectional and longitudinal changes in the erythrocyte sedimentation rate in men. J Gerontol. 1981;36(2):180–4.

    PubMed  CAS  Google Scholar 

  31. Gilbertsen VA. Erythrocyte sedimentation rates in older patients. A study of 4,341 cases. Postgrad Med. 1965;38(5):A44–52.

    PubMed  CAS  Google Scholar 

  32. Bottiger LE, Svedberg CA. Normal erythrocyte sedimentation rate and age. Br Med J. 1967;2(5544):85–7.

    Article  PubMed  CAS  Google Scholar 

  33. Miller A, Green M, Robinson D. Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J Clin Res Ed. 1983;286(6361):266.

    Article  PubMed  CAS  Google Scholar 

  34. Hanger HC, Sainsbury R, Gilchrist NL, Beard ME. Erythrocyte sedimentation rates in the elderly: a community study. N Z Med J. 1991;104(909):134–6.

    PubMed  CAS  Google Scholar 

  35. Cullen JF. Occult temporal arteritis. Trans Ophthalmol Soc UK. 1963;83:725–36.

    PubMed  CAS  Google Scholar 

  36. Bethlenfalvay NC, Nusynowitz ML. Temporal arteritis: a rarity in the young adult. Arch Intern Med. 1964;114:487–9.

    PubMed  CAS  Google Scholar 

  37. Eagling EM, Sanders MD, Miller SJ. Ischaemic papillopathy. Clinical and fluorescein aniographic review of forty cases. Br J Ophthalmol. 1974;58(12):990–1008.

    Article  PubMed  CAS  Google Scholar 

  38. Kansu T, Corbett JJ, Savino P, Schatz NJ. Giant cell arteritis with normal sedimentation rate. Arch Neurol. 1977;34(10):624–5.

    PubMed  CAS  Google Scholar 

  39. Wong RL, Korn JH. Temporal arteritis without an elevated erythrocyte sedimentation rate. Case report and review of the literature. Am J Med. 1986;80(5):959–64.

    Article  PubMed  CAS  Google Scholar 

  40. Grodum E, Petersen HA. Temporal arteritis with normal erythrocyte sedimentation rate. J Intern Med. 1990;227(4):279–80.

    Article  PubMed  CAS  Google Scholar 

  41. Jundt JW, Mock D. Temporal arteritis with normal erythrocyte sedimentation rates presenting as occipital neuralgia. Arthritis Rheum. 1991;34(2):217–9.

    Article  PubMed  CAS  Google Scholar 

  42. Wise CM, Agudelo CA, Chmelewski WL, McKnight KM. Temporal arteritis with low erythrocyte sedimentation rate: a review of five cases. Arthritis Rheum. 1991;34(12):1571–4.

    Article  PubMed  CAS  Google Scholar 

  43. Neish PR, Sergent JS. Giant cell arteritis. A case with unusual neurologic manifestations and a normal sedimentation rate. Arch Intern Med. 1991;151(2):378–80.

    Article  PubMed  CAS  Google Scholar 

  44. Hayreh SS, Zimmerman B. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies. Ophthalmologica. 2003;217(4):239–59.

    Article  PubMed  Google Scholar 

  45. Small JM, Ga Vrilescu K. The serum protein changes in giant cell arteritis. J Neurol Neurosurg Psychiatry. 1963;26:257–61.

    Article  PubMed  CAS  Google Scholar 

  46. Eshaghian J, Goeken JA. C-reactive protein in giant cell (cranial, temporal) arteritis. Ophthalmology. 1980;87(11):1160–6.

    PubMed  CAS  Google Scholar 

  47. Espinoza LR, Jara LJ, Silveira LH, Martinez-Osuna P, Zwolinska JB, Kneer C, et al. Anticardiolipin antibodies in polymyalgia rheumatica-giant cell arteritis: association with severe vascular complications. Am J Med. 1991;90(4):474–8.

    Article  PubMed  CAS  Google Scholar 

  48. Berthelot JM, Lamour A, Mottier D, Pennec YL, Dueymes M, Jouquan J, et al. Anti-neutrophil cytoplasm antibodies in patients with giant cell arteritis and/or polymyalgia rheumatica. Ann Med Interne (Paris). 1992;143(7):429–32.

    CAS  Google Scholar 

  49. Deodhar SD. C-reactive protein: the best laboratory indicator available for monitoring disease activity. Cleve Clin J Med. 1989;56(2):126–30.

    PubMed  CAS  Google Scholar 

  50. Parikh M, Miller NR, Lee AG, Savino PJ, Vacarezza MN, Cornblath W, et al. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology. 2006;113(10):1842–5.

    Article  PubMed  Google Scholar 

  51. Weyand CM, Fulbright JW, Hunder GG, et al. Treatment of giant cell arteritis: Interleukin-6 as a biologic marker of disease activity. Arthritis Rheum. 2000;43:1041–8.

    Article  PubMed  CAS  Google Scholar 

  52. Olhagen B. Polymyalgia rheumatica. A form of senile arteritis? Acta Rheumatol Scand. 1963;9:157–64.

    Article  PubMed  CAS  Google Scholar 

  53. Malmvall BE, Bengtsson BA. Giant cell arteritis. Clinical features and involvement of different organs. Scand J Rheumatol. 1978;7(3):154–8.

    Article  PubMed  CAS  Google Scholar 

  54. Bergström AL, Bengtsson BA, Olsson LB, Malmvall BE, Kutti J. Thrombokinetics in giant cell arteritis, with special reference to corticosteroid therapy. Ann Rheum Dis. 1979;38(3):244–7.

    Article  PubMed  Google Scholar 

  55. Giordano M. Thrombocytosis in giant cell arteritis. Ann Rheum Dis. 1980;39(3):298.

    Article  PubMed  CAS  Google Scholar 

  56. Calamia KT, Hunder GG. Clinical manifestations of giant-cell (temporal) arteritis. Clin Exp Rheumatol. 1980;6(2):389–403.

    Google Scholar 

  57. Calamia KT, Hunder GG. Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin. Arthritis Rheum. 1981;24(11):1414–8.

    Article  PubMed  CAS  Google Scholar 

  58. Riddle JM, Bluhm GB, Pitchford WC, McElroy H, Jimenea C, Leisen J, et al. A comparative study of platelet reactivity in arthritis. Ann NY Acad Sci. 1981;370:22–9.

    Article  PubMed  CAS  Google Scholar 

  59. Bengtsson BA. Hematological observations in giant cell arteritis. Acta Med Scand. 1982;658(Suppl):44–7.

    Google Scholar 

  60. De Keyser J, De Klippel N, Ebinger G. Thrombocytosis and ischaemic complications in giant cell arteritis. BMJ. 1991;303(6806):825.

    Article  PubMed  Google Scholar 

  61. Price N, Clearkin LG. Thrombocytosis and giant cell arteritis. Lancet. 1994;343(8898):672.

    Article  PubMed  CAS  Google Scholar 

  62. Krishna R, Kosmorsky GS. Implications of thrombocytosis in giant cell arteritis. Am J Ophthalmol. 1997;124(1):103.

    PubMed  CAS  Google Scholar 

  63. González-Gay MA, García-Porrua C, Vázquez-Caruncho M. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. J Rheumatol. 1998;25(9):1750–5.

    PubMed  Google Scholar 

  64. Lincoff NS, Erlich PD, Brass LS. Thrombocytosis in temporal arteritis rising platelet counts: a red flag for giant cell arteritis. J Neuroophthalmol. 2000;20(2):67–72.

    PubMed  CAS  Google Scholar 

  65. Hu Z, Yang Q, Zheng S, Tang J, Lu W, Xu N, et al. Temporal arteritis and fever: report of a case and a clinical reanalysis of 360 cases. Angiology. 2000;51(11):953–8.

    Article  PubMed  CAS  Google Scholar 

  66. Vrij AA, Rijken J, Van Wersch JW, Stockbrugger RW. Platelet factor 4 and ß-thromboglobulin in inflammatory bowel disease and giant cell arteritis. Eur J Clin Invest. 2000;30(3):188–94.

    Article  PubMed  CAS  Google Scholar 

  67. Gonzalez-Alegre P, Ruiz-Lopez AD, Abarca-Costalago M, Gonzalez-Santos P. Increment of the platelet count in temporal arteritis: response to therapy and ischemic complications. Eur Neurol. 2001;45(1):43–5.

    Article  PubMed  CAS  Google Scholar 

  68. Liozon E, Herrmann F, Ly K, Robert PY, Loustaud V, Soria P, et al. Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med. 2001;111(3):211–7.

    Article  PubMed  CAS  Google Scholar 

  69. Foroozan R, Danesh-Meyer H, Savino PJ, Gamble G, Mekari-Sabbagh ON, Sergott RC. Thrombocytosis in patients with biopsy-proven giant cell arteritis. Ophthalmology. 2002;109(7):1267–71.

    Article  PubMed  Google Scholar 

  70. Costello F, Zimmerman MB, Podhajsky PA, Hayreh SS. Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy. Eur J Ophthalmol. 2004;14(3):245–57.

    PubMed  CAS  Google Scholar 

  71. Gibb WR, Urry PA, Lees AJ. Giant cell arteritis with spinal cord infarction and basilar artery thrombosis. J Neurol Neurosurg Psychiatry. 1985;48(9):945–8.

    Article  PubMed  CAS  Google Scholar 

  72. Kaiser M, Weyand CM, Bjornsson J, Goronzy JJ. Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis. Arthritis Rheum. 1998;41(4):623–33.

    Article  PubMed  CAS  Google Scholar 

  73. Cid MC, Font C, Oristrell J, de la Sierra A, Coll-Vinent B, Lopez-Soto A, et al. Association between strong ­inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum. 1998;41(1):26–32.

    Article  PubMed  CAS  Google Scholar 

  74. Harrell FE. The LOGIST Procedure. SUGI Supplemental Library User’s Guide. NC: SAS Institute Inc; 1986. p. 269–93. Chapter 23, Version5. Cary.

    Google Scholar 

  75. Moncada S, Vanse JR. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med. 1979;300:1142–7.

    Article  PubMed  CAS  Google Scholar 

  76. Wu KK. Platelet hyperaggregability and thrombosis in patients with thrombocythemia. Ann Intern Med. 1978;88(1):7–11.

    PubMed  CAS  Google Scholar 

  77. Singh (Hayreh) S, Dass R. The central artery of the retina. I. Origin and course. Br J Ophthalmol. 1960;44:193–212.

    Article  Google Scholar 

  78. Pearson TC. The risk of thrombosis in essential thrombocythemia and polycythemia vera. Semin Oncol. 2002;29(3 Suppl 10):16–21.

    Article  PubMed  Google Scholar 

  79. Russell RWR. Giant cell arteritis. Q J Med. 1959;28:471–89.

    Google Scholar 

  80. Hedges 3rd TR, Gieger GL, Albert DM. The clinical value of negative temporal artery biopsy specimens. Arch Ophthalmol. 1983;101(8):1251–4.

    PubMed  Google Scholar 

  81. Breuer GS, Nesher R, Nesher G. Effect of biopsy length on the rate of positive temporal artery biopsies. Clin Exp Rheumatol. 2009;27(1 Suppl 52):S10–13.

    PubMed  CAS  Google Scholar 

  82. Dimitrijevic I, Malmsjo M, Andersson C, Rissler P, Edvinsson L. Increased angiotensin II type 1 receptor expression in temporal arteries from patients with giant cell arteritis. Ophthalmology. 2009;116(5):990–6.

    Article  PubMed  Google Scholar 

  83. Boyev LR, Miller NR, Green WR. Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis. Am J Ophthalmol. 1999;128(2):211–5.

    Article  PubMed  CAS  Google Scholar 

  84. Pless M, Rizzo 3rd JF, Lamkin JC, Lessell S. Concordance of bilateral temporal artery biopsy in giant cell arteritis. J Neuroophthalmol. 2000;20(3):216–8.

    PubMed  CAS  Google Scholar 

  85. Danesh-Meyer HV, Savino PJ, Eagle Jr RC, Kubis KC, Sergott RC. Low diagnostic yield with second biopsies in suspected giant cell arteritis. J Neuroophthalmol. 2000;20(3):213–5.

    PubMed  CAS  Google Scholar 

  86. Achkar AA, Lie JT, Hunder GG, O’Fallon WM, Gabriel SE. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med. 1994;120(12):987–92.

    PubMed  CAS  Google Scholar 

  87. Ray-Chaudhuri N, Kine DA, Tijani SO, Parums DV, Cartlidge N, Strong NP, et al. Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Ophthalmol. 2002;86(5):530–2.

    Article  PubMed  CAS  Google Scholar 

  88. Cullen JF. Temporal arteritis. Occurrence of ocular complications 7 years after diagnosis. Br J Ophthalmol. 1972;56(8):584–8.

    Article  PubMed  CAS  Google Scholar 

  89. Cohen DN. Temporal arteritis: improvement in visual prognosis and management with repeat biopsies. Trans Am Acad Ophthalmol Otolaryngol. 1973;77(1):OP74–85.

    PubMed  CAS  Google Scholar 

  90. Blumberg S, Giansiracusa DF, Docken WP, Kantrowitz FG. Recurrence of temporal arteritis. Clinical recurrence nine years after initial illness. JAMA. 1980;244(15):1713.

    Article  PubMed  CAS  Google Scholar 

  91. Graham E, Holland A, Avery A, Russell RW. Prognosis in giant-cell arteritis. Br Med J Clin Res Ed. 1981;282(6260):269–71.

    Article  PubMed  CAS  Google Scholar 

  92. Gouet D, Marechaud R, Le Berre D, Alcalay M, Becq-Giraudon B, Boissonnot L, et al. Pronostic de l’arterite temporale traitee. Etude retrospective de 87 observations. [Prognosis of treated temporal arteritis. Retrospective study of 87 cases]. Presse Méd. 1986;15(13):603–6.

    PubMed  CAS  Google Scholar 

  93. Schmidt WA, Kraft HE, Vorpahl K, Volker L, Gromnica-Ihle EJ. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med. 1997;337(19):1336–42.

    Article  PubMed  CAS  Google Scholar 

  94. Schmidt WA. Doppler ultrasonography in the diagnosis of giant cell arteritis. Clin Exp Rheumatol. 2000;18(4 Suppl 20):S40–42.

    PubMed  CAS  Google Scholar 

  95. Stammler F, Ysermann M, Mohr W, Kuhn C, Goethe S. Stellenwert der farbkodierten Duplexsonographie bei Patienten mit Polymyalgia rheumatica ohne klinische Zeichen einer Arteriitis temporalis. [Value of color-coded duplex ultrasound in patients with polymyalgia rheumatica without signs of temporal arteritis]. Dtsch Med Wochenschr. 2000;125(42):1250–6.

    Article  PubMed  CAS  Google Scholar 

  96. Schmid R, Hermann M, Yannar A, Baumgartner RW. Farbduplexsonographie der temporalarterien: biopsieersatz bei arteriitis temporalis? [Color duplex ultrasound of the temporal artery: replacement for biopsy in temporal arteritis]. Ophthalmologica. 2002;216(1):16–21.

    Article  PubMed  Google Scholar 

  97. Pfadenhauer K, Weber H. Duplex sonography of the temporal and occipital artery in the diagnosis of temporal arteritis A prospective study. J Rheumatol. 2003;30(10):2177–81.

    PubMed  Google Scholar 

  98. Schmidt D, Hetzel A, Reinhard M, Auw-Haedrich C. Comparison between color duplex ultrasonography and histology of the temporal artery in cranial arteritis (giant cell arteritis). Eur J Med Res. 2003;8(1):1–7.

    PubMed  Google Scholar 

  99. Vianna RN, Mansour M, Ozdal PC, Souza Filho JP, Bakalian S, Saraiva VS, et al. The role of ultrasound biomicroscopy in predicting the result of temporal artery biopsy in temporal arteritis patients: a preliminary study. Eur J Ophthalmol. 2005;15(6):655–9.

    PubMed  CAS  Google Scholar 

  100. Pfadenhauer K, Weber H. Ultrasonography of the temporal, periorbital and carotid arteries in the diagnosis of giant cell arteritis and its neuroophthalmological complications. Ultraschall Med. 2006;27(4):329–35.

    Article  PubMed  CAS  Google Scholar 

  101. Pérez López J, Solans Laqué R, Bosch Gil JA, Molina Cateriano C, Huguet Redecilla P, Vilardell Tarrés M. Colour-duplex ultrasonography of the temporal and ophthalmic arteries in the diagnosis and follow-up of giant cell arteritis. Clin Exp Rheumatol. 2009;27(1 Suppl 52):S77–82.

    PubMed  Google Scholar 

  102. Salvarani C, Silingardi M, Ghirarduzzi A, Lo Scocco G, Macchioni P, Bajocchi G, et al. Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis? Ann Intern Med. 2002;137(4):232–8.

    PubMed  Google Scholar 

  103. Bley TA, Brink I, Reinhard M. Bildgebende Verfahren bei Riesenzellarteriitis (M. Horton). [Imaging procedures for giant cell arteritis (Horton’s disease)]. Ophthalmologe. 2006;103(4):308–16.

    Article  PubMed  CAS  Google Scholar 

  104. Lauwerys BR, Puttemans T, Houssiau FA, Devogelaer JP. Color Doppler sonography of the temporal arteries in giant cell arteritis and polymyalgia rheumatica. J Rheumatol. 1997;24(8):1570–4.

    PubMed  CAS  Google Scholar 

  105. Ho AC, Sergott RC, Regillo CD, Savino PJ, Lieb WE, Flaharty PM, et al. Color doppler hemodynamics of giant cell arteritis. Arch Ophthalmol. 1994;112(7):938–45.

    PubMed  CAS  Google Scholar 

  106. Ghanchi FD, Williamson TH, Lim CS, Butt Z, Baxter GM, McKillop G, et al. Colour doppler imaging in giant cell (temporal) arteritis: serial examination and comparison with non-arteritic anterior ischaemic optic neuropathy. Eye (Lond). 1996;10(4):459–64.

    Google Scholar 

  107. Ghanchi FD, Dutton GN. Current concepts in giant cell (temporal) arteritis. Surv Ophthalmol. 1997;42(2):99–123.

    Article  PubMed  CAS  Google Scholar 

  108. Mitomo T, Funyu T, Takahashi Y, Murakami K, Koyama K, Kamio K. Giant cell arteritis and magnetic resonance angiography. Arthritis Rheum. 1998;41(9):1702.

    Article  PubMed  CAS  Google Scholar 

  109. Harada S, Mitsunobu F, Kodama F, Hosaki Y, Mifune T, Tsugeno H, et al. Giant cell arteritis associated with rheumatoid arthritis monitored by magnetic resonance angiography. Intern Med. 1999;38(8):675–8.

    Article  PubMed  CAS  Google Scholar 

  110. Lee AG, Eggenberger ER, Kaufman DI, Manrique C. Optic nerve enhancement on magnetic resonance imaging in arteritic ischemic optic neuropathy. J Neuroophthalmol. 1999;19(4):235–7.

    PubMed  CAS  Google Scholar 

  111. Stanson AW. Imaging findings in extracranial (giant cell) temporal arteritis. Clin Exp Rheumatol. 2000;18(4 Suppl 20):S43–48.

    PubMed  CAS  Google Scholar 

  112. Morgenstern KE, Ellis BD, Schochet SS, Linberg JV. Bilateral optic nerve sheath enhancement from giant cell arteritis. J Rheumatol. 2003;30(3):625–7.

    PubMed  Google Scholar 

  113. de Leeuw K, Bijl M, Jager PL. Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides. Clin Exp Rheumatol. 2004;22(6 Suppl 36):S21–26.

    PubMed  Google Scholar 

  114. Fletcher TM, Espinola D. Positron emission tomography in the diagnosis of giant cell arteritis. Clin Nucl Med. 2004;29(10):617–9.

    Article  PubMed  Google Scholar 

  115. Schmidt WA. Use of imaging studies in the diagnosis of vasculitis. Curr Rheumatol Rep. 2004;6(3):203–11.

    Article  PubMed  Google Scholar 

  116. Zborowska B, Ell J, McGhee-Collett M, Scolyer R, McCluskey PJ. Progressive visual loss in a patient with presumed temporal arteritis despite treatment: how to make the diagnosis. Clin Experiment Ophthalmol. 2004;32(3):335–6.

    Article  PubMed  Google Scholar 

  117. Blockmans D, de Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18 F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum. 2006;55(1):131–7.

    Article  PubMed  Google Scholar 

  118. Bley TA, Uhl M, Markl M, Frydrychowicz A, Langer M. Magnetresonanztomografie der arteriitis temporalis horton. [MRI in giant cell (temporal) arteritis]. Rofo. 2007;179(7):703–11.

    PubMed  CAS  Google Scholar 

  119. Bley TA, Uhl M, Carew J, Markl M, Schmidt D, Peter HH, et al. Diagnostic value of high-resolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol. 2007;28(9):1722–7.

    Article  PubMed  CAS  Google Scholar 

  120. Both M, Ahmadi-Simab K, Reuter M, Dourvos O, Fritzer E, Ullrich S, et al. MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis. Ann Rheum Dis. 2008;67(7):1030–3.

    Article  PubMed  CAS  Google Scholar 

  121. Reinhard M, Schmidt WA, Hetzel A, Bley TA. Bildgebung der riesenzellarteriitis. Sonographie und MRT. [Imaging techniques for giant cell arteritis. Ultrasound and MRI]. Z Rheumatol. 2009;68(2):108–16.

    Article  PubMed  CAS  Google Scholar 

  122. Hayreh SS. Inter-individual variation in blood supply of the optic nerve head. Its importance in various ischemic disorders of the optic nerve head, and glaucoma, low-tension glaucoma and allied disorders. Doc Ophthalmol. 1985;59(3):217–46.

    Article  PubMed  CAS  Google Scholar 

  123. Hayreh SS. Ischemic optic neuropathy. Prog Retin Eye Res. 2009;28(1):34–62.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology and Visual Science, University of Iowa Hospital and Clinics College of Medicine, Hawkins Dr. 200, Iowa City, IA, 52242–1091, USA

    Dr. Sohan Singh Hayreh

Authors
  1. Dr. Sohan Singh Hayreh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sohan Singh Hayreh .

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Hayreh, S.S. (2011). Diagnostic Criteria for Giant Cell Arteritis. In: Ischemic Optic Neuropathies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11852-4_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-11852-4_11

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-11849-4

  • Online ISBN: 978-3-642-11852-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation